Allergan CEO looks smart for pledging to rein in prices. But will it make a difference?
(By Ed Silverman for STAT) How much credit should we give Brent Saunders for trying to put a lid1 on
Read More
Part D/Prescription Drugs
All that pharmaceutical advertising may be a ‘mixed bag,’ after all
(By Ed Silverman for STAT) Amid the ongoing debate over the wisdom of pharmaceutical advertising, a new analysis suggests that
Read MoreJ&J to start testing vaccine for Ebola strains, Marburg virus
(By Helen Branswell for STAT) Johnson & Johnson will soon start testing a vaccine the world badly needs — one
Read MoreAs More States Consider Legalizing, Questions About Pot And The Brain
(By Martha Bebinger for NPR) Five states are voting this fall on whether marijuana should be legal, like alcohol, for
Read MoreKratom Advocates Speak Out Against Proposed Government Ban
(By Lauren Silverman for NPR) Kratom is made from the leaves of a small tree native to Southeast Asia that
Read MoreStudy: Health Spending Related To Opioid Treatment Rose More Than 1,300 Percent
(By Julie Appleby for Kaiser Health News) The nation’s ongoing opioid problem comes with staggering physical and emotional costs to
Read MoreFDA weighs crackdown that could shut hundreds of stem cell clinics
(By Usha Lee McFarling for STAT) Scientists on Monday will urge the Food and Drug Administration to crack down on
Read More5 reasons why no one has built a better EpiPen
(By Meghana Keshavan for STAT) Boston mom Denise Clark has been buying EpiPens annually for the past 16 years, ever
Read MoreGet Set for 2017 Medicare Changes
Open Enrollment is hurtling toward us, so now’s a good time to start thinking about the decisions you’ll need to
Read MoreMeet the man who’s the federal government’s pot dealer
(By Andrew Joseph for STAT) Mahmoud ElSohly oversees acres of marijuana plants in the deep south, a swath of the
Read More